Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia (Q46882666)

26 December 2017

title

Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

23 November 2022

1 reference

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786231

23 November 2022

2

D F Horrobin

1 reference

26 December 2017

author name string

C. Bates

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786231

23 November 2022

D. F. Horrobin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786231

23 November 2022

K. Ells

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1786231

23 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

26 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:092099649190014I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

https://api.elsevier.com/content/article/PII:092099649190014I?httpAccept=text/plain

23 November 2022

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

23 November 2022

published in

Schizophrenia Research

1 reference

26 December 2017

volume

6

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

1-7

1 reference

26 December 2017

γ-Linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome Δ6-desaturase activity

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Neurotransmitter modulation of prostaglandin E1-stimulated increases in cyclic AMP. I. Characterization of a cultured neuronal cell line in exponential growth phase

23 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Fat consumption and schizophrenia.

23 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Possible association of schizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis

23 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Fatty acid effects on angiotensin receptors

23 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Reduction of opioid binding in neuroblastoma x glioma cells grown in medium containing unsaturated fatty acids

23 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Schizophrenia as a prostaglandin deficiency disease

23 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Schizophrenia: Reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal

23 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism

23 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action

23 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Prostaglandins and schizophrenia: further discussion of the evidence

23 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Essential fatty acids in plasma phospholipids in schizophrenics

23 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan

23 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Effects of prostaglandins on baseline pressure and responses to noradrenaline in a perfused rat mesenteric artery preparation. PGE1 as an antagonist of PGE2

23 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Fatty acids in plasma and red cell membranes in normal humans

23 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Effect of intracisternal administration of prostaglandin E1 on waking and sleep in the rat

23 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Inhibition of the binding of R-5020 and rat uterine progesterone receptors by long chain fatty acids

23 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

23 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

23 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Polyunsaturated fatty acids, prostaglandins, and schizophrenia

23 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders

23 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90014-I

23 November 2022

Identifiers

1 reference

26 December 2017

1 reference

26 December 2017